Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
2
.
Show all posts
Showing posts with label
2
.
Show all posts
Thursday, July 23, 2015
Effimune obtains regulatory approval for Phase I clinical trial in humans of its new immunomodulator FR104
›
Effimune announced today that it had received the authorization from the Belgian regulatory authority, the FAMHP (Federal Agency for ...
Thursday, July 5, 2012
Study shows how a drug-lead compound suppresses tumour formation
›
Study shows how a drug-lead compound suppresses tumour formation : A team of scientists from the National University of Singapore's (N...
›
Home
View web version
